You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tusamitamab ravtansine

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-squamous Non-small-cell Lung Cancer Trial in Hangzhou (Tusamitamab ravtansine+Sintilimab+Carboplatin or

Not yet recruiting
  • Non-squamous Non-small-cell Lung Cancer
  • Tusamitamab ravtansine+Sintilimab+Carboplatin or Cisplatin+Pemetrexed
  • +2 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
May 5, 2023

Tumor Trial (Tusamitamab ravtansine)

Not yet recruiting
  • Neoplasm
  • Tusamitamab ravtansine
  • (no location specified)
Jun 22, 2022

Metastatic Lung Cancer, Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Rotterdam (Tusamitamab ravtansine)

Not yet recruiting
  • Metastatic Lung Cancer
  • +2 more
  • Tusamitamab ravtansine
  • Rotterdam, Netherlands
    Erasmus MC
Jan 26, 2023

Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC) Trial in Worldwide (SAR408701 (Tusamitamab ravtansine), Pembrolizumab,

Recruiting
  • Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)
  • SAR408701 (Tusamitamab ravtansine)
  • +4 more
  • Westwood, Kansas
  • +26 more
Aug 11, 2022

Adenocarcinoma Gastric, Gastrooesophageal Cancer Trial in Worldwide (Ramucirumab (CYRAMZA®), Tusamitamab ravtansine (SAR408701))

Recruiting
  • Adenocarcinoma Gastric
  • Gastrooesophageal Cancer
  • Ramucirumab (CYRAMZA®)
  • Tusamitamab ravtansine (SAR408701)
  • Bruxelles, Belgium
  • +22 more
Jan 16, 2023

Non-squamous NSCLC Trial in Worldwide (Tusamitamab ravtansine)

Recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • Tusamitamab ravtansine
  • Edegem, Belgium
  • +18 more
Aug 3, 2022

Tumor Malignant Trial in Kashiwa-Shi, Nagoya-Shi, Sunto-Gun (SAR408701, dexamethasone, naphazoline)

Completed
  • Neoplasm Malignant
  • Kashiwa-Shi, Japan
  • +2 more
Jan 6, 2023

Pleural Malignant Mesothelioma Trial in Canada, United States (Anetumab Ravtansine, Laboratory Biomarker Analysis,

Active, not recruiting
  • Pleural Malignant Mesothelioma
  • Anetumab Ravtansine
  • +3 more
  • Birmingham, Alabama
  • +32 more
Dec 24, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in Canada,

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +5 more
  • Anetumab Ravtansine
  • +5 more
  • Birmingham, Alabama
  • +44 more
Feb 2, 2023

Mesothelin Positive, Stage III NSCLC AJCC v7, Stage IIIA NSCLC AJCC v7 Trial in Phoenix, Jacksonville, Rochester (Anetumab

Terminated
Has Results
  • Mesothelin Positive
  • +4 more
  • Anetumab Ravtansine
  • +2 more
  • Phoenix, Arizona
  • +2 more
Jan 5, 2023

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma

Active, not recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +7 more
  • Anetumab Ravtansine
  • +2 more
  • Orange, California
  • +22 more
Oct 22, 2022

Tumors Trial in France, Moldova, Republic of (Anetumab ravtansine (BAY94-9343))

Completed
  • Neoplasms
  • Anetumab ravtansine (BAY94-9343)
  • Caen, France
  • +7 more
Jul 6, 2021

Pancreatic Cancer Trial in New Haven, New Brunswick, Nashville (anetumab ravtansine)

Completed
Has Results
  • Pancreatic Cancer
  • anetumab ravtansine
  • New Haven, Connecticut
  • +2 more
Oct 11, 2021

Mesothelioma Trial in Worldwide (Anetumab ravtansine (BAY94-9343), Vinorelbine)

Completed
Has Results
  • Mesothelioma
  • La Jolla, California
  • +74 more
Oct 28, 2020

Medical Oncology Trial in Worldwide (Anetumab ravtansine (BAY94-9343), Itraconazole)

Completed
  • Medical Oncology
  • Santa Monica, California
  • +17 more
Jul 29, 2020

Ovarian Tumors Trial in Worldwide (Anetumab ravtansine (BAY94-9343), Pegylated Liposomal Doxorubicin)

Completed
  • Ovarian Neoplasms
  • Anetumab ravtansine (BAY94-9343)
  • Pegylated Liposomal Doxorubicin
  • Aurora, Colorado
  • +8 more
Nov 21, 2019

Medical Oncology Trial in Italy, United States (BAY 94-9343, Pemetrexed, Cisplatin)

Completed
  • Medical Oncology
  • BAY 94-9343
  • +2 more
  • Chicago, Illinois
  • +5 more
Nov 6, 2019

Lung Tumors Trial run by the NCI (Anetumab Ravtansine, Blood test)

Terminated
Has Results
  • Lung Neoplasms
  • Anetumab Ravtansine
  • Blood test
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 30, 2019